Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?

Statins (hydroxymethylglutaryl-coenzyme-A reductase inhibitors) are first-line agents for the management of hyperlipidemia in patients at high risk of cardiovascular (CV) events, and are the most commonly prescribed CV drugs worldwide. Although safe and generally well tolerated, there is growing evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarese, Eliano Pio, Szczesniak, Anna, Kolodziejczak, Michalina, Gorny, Bartosz, Kubica, Jacek, Suryapranata, Harry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961631/
https://www.ncbi.nlm.nih.gov/pubmed/24174174
http://dx.doi.org/10.1007/s40256-013-0053-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961631/
https://www.ncbi.nlm.nih.gov/pubmed/24174174
http://dx.doi.org/10.1007/s40256-013-0053-0

Ejemplares similares